1. |
Hirtz D, Thurman DJ, Gwinn-Hardy K, et al. How common are the common neurologic disorders? Neurology, 2007, 68(5): 326-337.
|
2. |
Brodie MJ, Dichter MA. Antiepileptic drugs. N Engl J Med, 1996, 334(3): 168-175.
|
3. |
Giráldez BG, Toledano R, García-morales I, et al. Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluation. Seizure, 2015, 29(1): 119-122.
|
4. |
Cawello W, Stockis A, Andreas JO, et al. Advances in epilepsy treatment: lacosamide pharmacokinetic profle. Ann NY Acad Sci, 2014, 1329(1): 18-32.
|
5. |
中华医学会儿科学分会神经学组生酮饮食疗法协作组. 长期生酮饮食治疗儿童难治性癫痫的前瞻性多中心研究. 中华儿科杂志, 2013, 51(4): 276-282.
|
6. |
Gavatha M, Ioannou I, Papavasiliou AS. Efficacy and tolerability of oral lacosamide as adjunctive therapy in pediatric patients with pharmaco resistant focal epilepsy. Epilepsy Behav, 2011, 20(6): 691-693.
|
7. |
Heyman E, Lahat E, Levin N, et al. Preliminary efficacy and safety of lacosamide in children with refractory epilepsy. Eur J Paediatr Neurol, 2012, 16(1): 15-19.
|
8. |
Yorns WR, Khurana DS, Carvalho KS, et al. Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy. J Child Neurol, 2014, 29(1): 23-27.
|
9. |
Guilhoto LM, Loddenkemper T, Gooty VD, et al. Experience with lacosamide in a series of children with drug-resistant focal epilepsy. Pediatr Neurol, 2011, 44(3): 414-419.
|
10. |
Rastogi RG, Ng Y. Lacosamide in refractory mixed pediatric epilepsy: a prospective add-on study. J Child Neurol, 2012, 27(4): 492-495.
|
11. |
Miskin Chandrabhaga, Khurana Divya S, Valencia Ignacio, et al. Efficacy and tolerability of Lacosamide in the treatment of children with refractory generalized epilepsy. Journal of Child Neurology, 2016, 31(7): 925-928.
|
12. |
Farkas V, Steinborn B, Flamini JR, et al. Efficacy and tolerability of adjunctive Lacosamide in children and adolescents with uncontrolled focal seizures: a randomized, double-blind, placebo-controlled trial. Poster presented at American Epilepsy Society Annual Meeting, 2017: 1-5, Washington, DC, USA.
|
13. |
Wehnert, Bauers, Hamrh M, et al. Six months of postmarketing experience with adjunctive lacosamide in patients with pharmacoresistant focal epilepsy at a tertiary epilepsy center in Germany. Epilepsy Behav, 2009, 16(3): 423-425.
|
14. |
Bialer, Johannesseni, Levyr, et al. Progress reporton new antiepileptic drugs: A summary of the ninth eilat conference (EILATIX). Epilepsy Res, 2009, 83(1): 1-43.
|
15. |
Shaibania, Faress, Selam JL, et al. Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebocontrolled trial. J Pain, 2009, 10(8): 818-828.
|
16. |
Zangaladze A, Skidmore C. Lacosamide use in refractory idiopathic primary generalized epilepsy. Epilepsy Behav, 2012, 23(1): 79-80.
|
17. |
Biton V, Gil-Nagel A, Isojarvi J, et al. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials. Epilepsy Behav, 2015, 52(2): 119-127.
|